Monoclonal antibodies prepared against vaccine strains of yellow fever (YF) virus were initially characterized by fluorescence microscopy of Vero cells infected with YF virus strain 17D. When similarly tested against representatives of all flavivirus subgroups, the antibodies produced a wide spectrum of reactions ranging from the monospecific to the broadly cross-reactive; at least five antigenic domains in the YF virus envelope glycoprotein were identified. Monoclonal antibodies differentiated between YF virus vaccine strains (17D, 17DD, FNV), wild-type viruses and plaque variants selected from a 17D pool. One isolate from a patient with YF was antigenically similar to the Brazilian vaccine strain 17DD. Several of the antibodies reacting with the YF viral envelope glycoprotein in biological tests identified the 54K envelope glycoprotein; 45K and 26K polypeptides in YF 17D virus-infected cells were also identified by radioimmunoprecipitation and polyacrylamide gel electrophoresis. Neither of these polypeptides was found in uninfected cells. They may represent shortlived precursors of the 54K protein, post-translational cleavage or breakdown products. Other antibodies reacted with a 48K polypeptide in virus-infected cell lysates. This may be the non-structural NV3 protein described for YF virus. Its appearance on the surface of unfixed infected cells, but not on released virions, was demonstrated by fluorescence microscopy.
INTRODUCTION
Yellow fever (YF) virus is the type species of the genus Flavivirus (Wildy, 1971) which was originally placed in the family Togaviridae (Fenner et aL, 1974) but has been recently reclassified within the newly established family Flaviviridae (Brown, 1985) . Surprisingly, YF virus appears antigenically specific in flavivirus cross-neutralization tests (Madrid & Porterfield, 1974) . Nevertheless, YF virus wild-type and vaccine strains induce a broad heterotypic serological response in individuals with pre-existing flavivirus antibodies (Theiler & Casals, 1958; Pond et al., 1967) . This is partly explained by the recent studies of Monath et al. (1984) who showed with monoclonal antibodies that YF virus possesses antigenic determinants common to several flavivirus subgroups. The vaccine was derived empirically from a wild-type (Asibi) isolate of YF virus by 18 passages through minced mouse cells and then serial subculture in chick embryo tissue (Theiler & Smith, 1937) . Two distinct substrains (17D-204 and 17DD) provide the source of today's vaccines. In this paper, derivatives of the 17D-204 substrain will be referred to as lTD. Independently, a French vaccine was developed by serial passage of a wildtype YF virus isolate in adult mice. This is the French neurotropic virus (FNV) vaccine.
Despite the known success of YF virus vaccines in inducing immunity against wild-type YF virus infections (Theiler & Smith, 1937) there is still serious concern about the incidence of YF epidemics in South America and some parts of Africa. Furthermore, in the 17D vaccine, plaque variants with different virulence for mice have been reported (Liprandi, 1981) and 0000-6561 © 1985 SGM oligonucleotide fingerprint comparisons of the RNA of several vaccine viruses reported by Monath et al. (1983) also demonstrated some differences. In view of this and other evidence it has been suggested that the genetic stability of the seed virus used for the production of vaccine should be examined (Woodall, 1981) .
Reagents that can distinguish between vaccine and wild-type YF virus and also YF from other flaviviruses are needed to improve the ease and precision of diagnosis, to clarify antigenic interrelationships between these viruses and to map the envelope glycoprotein so that the immunogenic sites and the determinants of virulence can be identified. Here we describe some antigenic and molecular characteristics of monoclonal antibodies prepared against YF virus. The results demonstrate how monoclonal antibodies can be used in immunofluorescence tests to detect antigenic similarities between distantly related flaviviruses and also to distinguish between very closely related strains or variants of one virus. (Liprandi, 1981) were supplied by Dr S. Salum (Reading University, Reading, U.K.). Wild-type isolates of YF virus were either held as stocks in our Department after isolation by Dr C.Leake (London School of Hygiene, London, U.K.) or were obtained from Brazil by R. Ishak. The derivations and codes of each strain and substrain of YF virus used are presented in Table 1 . For stock virus each preparation was inoculated intracerebrally into two litters of newborn mice (strain TO). When the mice were sick, 20~ mouse brain suspensions in phosphate-buffered saline (PBS) were prepared and stored at -70 °C. For purified virus, Vero cells were infected with stock virus at an input multiplicity of 0.01 p.f.u./cell and incubated until the monolayers showed significant c.p.e. The supernatant medium was clarified by centrifugation at 3000 g for 15 min. Virus was then precipitated overnight by addition of NaCI (0.4 M) and 6 ~o polyethylene glycol (PEG). After centrifugation at 10000g for 30 rain the precipitate was re-dissolved to one-hundredth of the original volume in PBS and centrifuged on a 5 to 50 ~ sucrose gradient at 90 000 g for 3 h. One ml samples were collected and the purified virus was identified by haemagglutination tests (Clarke & Casals, 1958) .
METHODS

Viruses
In this paper the names of the viruses have been abbreviated according to the recommendations of the International Catalogue of Arboviruses (Berge, 1975) .
Cells and media.
Vero cells were subcultured in L 15 medium supplemented with 5 ~ foetal calf serum (FCS), and 10~ tryptose phosphate broth (growth medium). Maintenance medium contained 1 ~ FCS.
Hyperimmune antisera. Rabbit anti-YF (RHI) and West Nile (RH2) hyperimmune antisera were prepared by intramuscular inoculation of 0-5 ml of purified P 17D, or West Nile virus, mixed with an equal volume of complete Freund's adjuvant. Two, 3 and 4 weeks later, four doses of 0.05 ml of the virus were administered intradermally. After a further 5 days the serum was collected and stored at -20 °C. In haemagglutination inhibition tests these antisera had titres > 5000. Large and small plaque types derived from S17D Large, medium and small plaque types derived from W17D (Liprandi, 1981) YF vaccine from Brazil batch no. 230209; Bio-Manguinhos French neurotropic vaccine; Porton Down Asibi Y1 (Fitzgeorge & Bradish, 1980) Wild YF monkey serum (10/4/68); R. Fitzgeorge, Porton Down Wild YF (Fitzgeorge & Bradish, 1980) Wild YF monkey serum 10/1/75; Trinidad Wild YF (Varma et al., 1975/76) B1 wild YF monkey serum 1973; Brazil B2, 3, 6, 7, 9, 10, 12, 14, 15, 16, wild YF human serum 1978 Brazil B4, 5, 8, 11, 13, wild YF Haemagogus sp. 1973 /1980 Brazil Monoclonalantibodies. Female BALB/c mice were inoculated intraperitoneally (i.p.) with 0.1 ml of either P17D-or FNV-infected suckling mouse brain suspension. Animals were then rested for 5 weeks before repeating the i.p. injection. After 1 more week the mice were given three single i.p. injections at daily intervals. Spleens were removed on the fourth day and the procedure for fusion using PEG was that described by Chanas et al. (1982) .
Mouse ascites, from positive cloned cultures, with titres > 100000 were obtained when titrated by indirect immunofluorescence.
Immunofluorescenee. Indirect immunofluorescence tests were performed on unfixed and acetone-fixed infected Veto cells. Antibody test fluids were added to infected cells for 40 min at 37 °C followed by biotinylated mouse anti-globulin for 40 min and fluorescein-conjugated streptavidin (Amersham) for 15 min as described previously (Gould et al., 1985) .
Haemagglutination inhibition (HA1) test. This followed the procedure of Clarke & Casals (1958) Electron microscopy. Samples were fixed with 2.5~ glutaraldehyde in 0.1 ~t-cacodylate buffer pH 7-2. The cells were scraped off the plate and centrifuged at 1000 g for 15 min. The pellet was post-fixed in 1 ~ osmium tetroxide in cacodylate and embedded in resin. Sections obtained using an ultramicrotome were stained with 2~o uranyl acetate and lead citrate.
Radioimmunoprecipitation (RIP).
Vero or CV-1 cells were infected at an input multiplicity of 1 to 5 p.f.u./cell and incubated in L 15 maintenance medium. At 30 h post-infection 2 lag/ml actinolnycin D was added for 18 h at 37 °C. The medium was then replaced with methionine-deficient medium for 2 h followed by the addition of [3 sS]methionine (50 laCi/ml, sp. act. 800 Ci/mmol; Amersham) for 1 to 4 h at 37 °C. Monolayers were washed with cold PBS, then Vero cells were lysed with RIP buffer (2~ Triton X-100, 1 ~ NP40, 1 ~ sodium deoxycholate, 0-1 SDS in PBS at pH 7.4) and CV-I cells were lysed with 1 mM-phenylmethylsulphonyl fluoride, aprotinin (500 KIU/ml), 1~o Triton X-100, 0.1 ~ SDS. Lysates were clarified by centrifugation at 10000g for 15 min and stored at -70°C. For immunoprecipitation, antibody (20~o) was added to cell lysate overnight at room temperature then 40 ~tl of a 50~ (v/v) suspension of Protein A Sepharose CL-4B (Pharmacia) was added. After 2 h further incubation with occasional agitation, the beads were recovered by centrifugation at 12000 g for 2 min then washed three times with excess RIP buffer. The precipitated proteins were solubilized in 10 mM-Tris base containing 5~ glycerol, 5~o 2-mercaptoethanol and 2~ SDS. Prdteins were analysed by PAGE on 10 to 30~ gels (Cook et al., 1979) , then dried and autoradiographed.
RESULTS
Determination of the molecular specificities of the antibodies
The molecular specificity of each monoclonal antibody was determined with YF virusinfected cell lysates using RIP and PAGE analysis as described above. Many clones showed specificity for either the viral envelope glycoprotein (54K) or the non-structural protein (48K) of YF (W 17D)-infected cells (Fig. 1 a) . However, using a shorter labelling time of 1.5 to 2 h, some of the 54K-specific antibodies also precipitated a 45K and a 26K protein ( Fig. 1 b) neither of which was detected in uninfected cells. This could indicate that the 45K polypeptide is a short-lived precursor to the 54K envelope protein, since the 45K protein was not observed following radiolabelling for 4 h.
Immunofluorescence with monoclonal antibodies and flaviviruses
Monoclonal antibodies, specific for either the 54K or 48K protein, were tested for reactivity with a very wide range of flaviviruses using indirect immunofluorescence with the appropriate acetone-fixed infected Vero cells. The results are presented in Table 2 for the 54K and Table 3 for the 48K antibodies. Clones 86l and 864 (54K) exhibited unique reactivity with the 17D vaccine substrain of YF virus and clone 429 (48K) was unique for FNV. Clone 411 (54K) reacted with all YF vaccines and Y5 but no other viruses, whereas several other antibodies (54K-and 48K-specific) identified all YF Viruses but no other flaviviruses. Two more types of antibody were seen: those that identified all YF viruses and just one or two different flaviviruses (54K-and 48K-specific antibodies) and those that were very broadly cross-reactive with most or all viruses (only 54K). The results obtained with two hyperimmune rabbit antisera prepared against either Y F (RH l) or West Nile (RH2) purified virions are also included in Table 2 . These antisera, which precipitated only the 54K YF glycoprotein (not shown), also showed broad cross-reactivity, producing fluorescence with every virus tested. Evidence for antigenic variation in YF viruses was obtained from the following observations. Firstly, the medium plaque variant of YF 17D virus (RMP) did not react with antibody 411 (see Table 4 ). Secondly, several well-separated large and small plaque variants obtained from YF 17D virus (South African batch no. 8315) were individually isolated and tested by immunofluorescence for their reactivity with the monoclonal antibodies. Two small plaque variants were unusual in that they reacted only very weakly with clone 864 antibody although they reacted strongly with all other monoclonal antibodies. Thirdly, clone 612 reacted normally with all vaccine strains and most wild-type isolates; however, three of the 16 isolates from Brazil reacted only very weakly with clone 612 but normally with the other antibodies.
Immunofluorescence with monoclonal antibodies and YF viruses
Results of cross-immunofluorescence tests with yellow fever viruses using 54K and 48K monoclonal antibodies
Characteristics of immunofluorescence
Examination of the characteristics of immunofluorescence induced by these antibodies enabled us to identify, provisionally, those that recognized either cytoplasmic (internal) antigens exclusively or those that appeared on the surface of plasma membranes and virions. Fig. 2 (a) shows the typical fluorescence pattern produced by antibodies specific for the 54K polypeptide. Both cytoplasmic and surface fluorescence was produced but in addition distinct spots of fluorescence were usually present outside the infected cells. These were presumed to represent aggregates of virus particles (see Fig. 3 ). Further confirmation that the external side of the plasma membrane contained virus antigen was obtained using indirect immunofluorescence with unfixed Vero cells infected with YF 17D. Under these conditions, antibody did not penetrate the cells; instead, a broken line of fluorescence was clearly visible on the outside of infected cells (Fig. 2b) .
A second group of antibodies specific for the 54K protein produced extremely pronounced external fluorescence with acetone-fixed cells, making any internal staining impossible to visualize (Fig. 2c) . However, several antibodies that identified the 48K protein showed diffuse cytoplasmic staining without surface labelling (Fig. 2d) . Clone 979 (48K-specific), in contrast, produced a characteristic perinuclear halo of fluorescence arranged as small inclusions (Fig. 2 e) . With acetone-fixed cells there was no obvious surface fluorescence, but when unfixed cells were tested sparsely distributed fluorescent dots were visible along the plasma membrane of some infected cells, which suggests that the epitope recognized by clone 979 is acetone-sensitive.
The possibility of inherent heterogeneity in several of the Brazilian isolates was brought to light by the following observations with antibodies 423, 428, 992 and 993. Two patterns of fluorescent staining were produced by each antibody in different cells of the same infected cultures: either the inclusion type already shown in Fig. 2(e) or fibrillar cytoplasmic staining particularly in the perinuclear region (Fig. 2f) and reminiscent of some types of fluorescent labelling with antibodies directed against cellular components. The proportions of these two types of fluorescence varied with each isolate from exclusively one type to almost equal proportions of both. Moreover, antibody 492 usually produced Characteristic cytoplasmic inclusions with vaccine strains as shown in Fig. 2(g) . In contrast, with FNV virus the cytoplasmic staining was again perinuclear and fibrillar in the cytoplasm as is seen when intermediate filaments are stained (Fig. 2h) . Nevertheless, this fluorescence was virus-specific since the proportion of fluorescent cells always corresponded with the known proportion of virus-infected cells and was never present in uninfected cells.
Haemagglutination-inhibition and neutralization tests
Further identification of envelope-reactive monoclonal antibodies was achieved using HAI and PRNT tests. The results are presented in Table 5 which also shows the immunoglobulin subclass of each antibody as determined by Ouchterlony tests with the appropriate antiglobulins. Antibodies that did not produce surface immunofluorescence with acetone-fixed cells (48K) were also negative in HAI and PRNT tests. In general, antibodies specific for the 54K envelope glycoprotein exhibited both HAI and PRNT activity although some were negative in one or both tests. Antibody titres in all cases were very much lower than those determined by indirect immunofluorescence: for example, clone 864 had a fluorescence titre of 1/107, an HAI titre of 1/5260 and a PRNT of 1/2560. --492  IgG2a  --428  IgG2a  --863  IgG 1  --871  IgG2a  --979  IgG2a  --423  IgG2a  --992  IgG2a  --993  IgG2a  --999  IgG2a  --917  IgG2a  --924  IgM  --925 IgG 1 --* NT, Not tested.
Electron microscopy
Clone 864 antibody diluted 1/100 in PBS was added to monolayers of 17D virus-infected Vero cells for 1 h at 37 °C. The monolayers were then fixed with glutaraldehyde as described earlier and thin sections were prepared for electron microscopy. Controls were treated with an unrelated monoclonal antibody (clone 62.4a) prepared against JE virus (Gould et al., 1983) . The results confirmed those presented above, i.e. that fluorescent dots seen outside infected cells were virions. Packages of virus particles coated with antibody molecules were visible in the extracellular spaces (Fig. 3 a) . The detail of the envelope glycoprotein spikes on the virions was difficult to visualize because of the halo of antibody molecules. In contrast, the control virions had clearly defined envelope glycoprotein spikes (Fig. 3b) .
DISCUSSION
AS a result of the wide diversity of antibodies in conventional antisera it is difficult to make an unambiguous interpretation of antigenic cross-reactions among the flaviviruses. Because of their specificity, monoclonal antibodies can be used to circumvent these problems. Accordingly, a panel of monoclonal antibodies was prepared against YF virus and tested for reactivity in indirect immunofluorescence tests with representatives of all antigenic subgroups of the genus Flavivirus.
The radioimmunoprecipitation test revealed three specificities : antibodies that identified the 54K envelope glycoprotein alone, others recognizing the 54K, 45K and 26K polypeptides, and others specific for a 48K protein presumed to be equivalent to the non-structural NV3 protein described by Stohlman et al. (1976) and Schlesinger et al. 0983) . As yet, we cannot explain the unexpected appearance of bands at 45K and 26K with some of the envelope-specific antibodies. However, virus-specific bands at approximately 45K and 25K have been referred to previously (Westaway, 1980) and are considered to be non-structural. Whether they represent posttranslational cleavage products (26K) or a precursor (possibly a non-glycosylated form of mol. wt. 45K) of the 54K protein remains to be seen. The latter possibility is supported by experiments with an inhibitor of glycosylation, tunicamycin, in the presence of which the 45K polypeptide is labelled even in long labelling periods (A. Barrett, unpublished results). However, we have not yet excluded the possibility that they are breakdown products and this is being further investigated. It seems most unlikely that we have merely failed to clone the hybridomas since the most common method used was micromanipulation of single cells three times for each antibody.
By indirect immunofluorescence, epitopes on both the structural envelope glycoprotein and the non-structural NV3 protein of YF 17D virus were antigenically cross-reactive within the genus, although the broad cross-reactivity was seen only with antibodies specific for the 54K polypeptide. Detailed analysis of the data incorporating a wide selection of flaviviruses, YF vaccine strains and wild-type preparations, revealed extremes in the spectrum of reactivities from unique to broadly cross-reactive. Epitopes unique for 17D, FNV, vaccine strains of YF virus and all strains of YF virus were identified. Thus, since the 17DD vaccine strain produced a unique pattern of reactivity with these antibodies, we can distinguish individual vaccines and also identify wild-type viruses. Indeed, using this principle of unique reactivity patterns, each of the flaviviruses tested could be identified in just 3 h by indirect immunofluorescence. Previously, YF 17D virus and the parent Asibi virus were shown to differ serologically in HAI and PRNT tests (Clarke, 1960; Schlesinger et al., 1983) . It is not possible, however, in these functional tests to decide whether or not the relevant epitope has been lost since the tests depend upon the conformational arrangement of the epitopes as well as their presence.
In addition to the epitopes that were unique for YF virus, some were shared between YF and just one or two other flaviviruses, whereas others were common to virtually all flaviviruses. Therefore, on the basis of the immunofluorescence test alone we have identified five antigenic domains in the envelope glycoprotein of YF 17D virus, i.e. 17D-specific, vaccine-specific, YFspecific, YF intermediate and YF broad reactivity. Several groups of investigators have suggested different numbers of antigenic domains in flavivirus envelope glycoproteins (KimuraKuroda & Yasui, 1983; Heinz et al., 1983 ; Roehrig et al., 1983; Monath et al., 1984; Schlesinger et al., 1984) , but in each case the estimates have been based on more than one test and have usually included neutralization or haemagglutination. Since these tests may depend upon the topological disposition of the relevant epitopes and not simply their presence, negative reactions may be misleading. This might explain the variations in the number of domains predicted. It might also explain why South American and African strains appeared antigenically different when compared in HAI tests (Clarke, 1960) but identical in our immunofluorescence tests. Alternatively, the appropriate monoclonal antibodies still need to be identified.
Previously, monoclonal antibodies prepared against flaviviruses have demonstrated antigenic determinants common to more than one subgroup of the genus (Gould et al., 1983; Monath et al., 1984) . As far as we are aware, our work with monoclonal antibodies shows for the first time that one virus contains epitopes common to all subgroups including those with no known invertebrate vector.
It has been reported that there is a noticeable lack of antigenic cross-reactivity in neutralization tests between YF and other flaviviruses (Madrid & Porterfield, 1974; Calisher et al., 1982) . It is also known that immunization of humans with 17D vaccine does not always elicit detectable heterotypic neutralizing antibody responses unless they have been exposed to other related flaviviruses (Pond et al., 1967) . Perhaps our results with monoclonal and defined polyclonal antibodies reflect the relative location and immunological relevance of the antigenic domains within the envelope glycoprotein. For example, broadly cross-reactive antibodies, present in sera from natural infections, may not be detectable in many of the conventional tests due to either their low titres or masking by other higher titre antibody molecules. This idea was suggested previously for Sindbis virus antibodies (Chanas et al., 1982) . Furthermore, in the report of Schlesinger et al. (1983) , monoclonal antibodies were shown to exhibit broader cross-reactivity with other flaviviruses than are usually observed with conventional antisera. Taking our observations into account, therefore, the position of YF virus as the prototype of the genus Flavivirus seems justified.
In depth analysis of the YF virus strains also showed several other interesting features. Until recently, we have used conventional indirect immunofluorescence microscopy, i.e. not incorporating biotin and streptavidin. With the conventional system, three wild-type isolates of YF virus were negative when tested with clone 612 and in addition two small plaque variants, selected from the 17D vaccine (South African), were negative against clone 864 antibody. With the biotin-streptavidin system, weak but definite positive reactions were obtained, as presented in this paper. These differences in the affinity of antibody reactions with variants probably reflect different conformations of epitopes in the envelope glycoprotein.
The existence of heterogeneity in the wild-type isolates was shown by mixed fluorescent staining patterns produced by individual antibodies. That the appearance of the fluorescence produced by antibody 492 with FNV was also different from that produced with other vaccine strains suggests the possibility that modified replicative processes might occur with some YF virus variants. We are currently looking at this in relation to the different virulence characteristics (Theiler & Downs, 1973 ) of these viruses.
When acetone-fixed cells were examined by immunofluorescence, the antigen represented by clone 979 antibody could be seen only in the perinuclear region of the cytoplasm (Fig. 2e) , whereas other clones produced distinct spots both on and outside the plasma membrane. By immune electron microscopy we were able to demonstrate YF virus particles coated with antibody molecules outside infected cells, thus confirming our interpretation of the immunofluorescence results. In contrast, with unfixed infected cells, antibody 979 produced fluorescent labelling on the outside surface of infected cells, suggesting that it identified an acetone-sensitive epitope. Acetone sensitivity of haemolysin was reported for measles virus (Armstrong et al., 1979) and canine distemper virus (Gould et al., 1981) . In addition, the haemolysin of Sindbis virus was reported to be ether-sensitive (Chanas et al., 1982) . Whether or not YF virus possesses a haemolysin has not yet been reported; however, haemolysis has been reported for JE virus (Karabatsos, 1965) and we have now defined methods for demonstrating haemolysis by several flaviviruses (unpublished).
Finally, there is a need to develop rapid and precise methods for diagnosing flaviviruses that arise in epidemic situations. We have demonstrated in this paper that monoclonal antibodies can be used for this purpose. Indirect immunofluorescence is reliable and sensitive but requires considerable experience in its application and is not ideal for these purposes. We are currently developing ELISA tests for use with the above monoclonal antibodies to overcome these problems.
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